MARTELL RON (President, CEO and Director) purchased 123.8% of their position (41K shares) of JASPER THERAPEUTICS, INC. on the open market
Open‑market purchase worth $99.6K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/24/2025ACC: 0001213900-25-091099
DirectorOfficer· President, CEO and Director
Since Mar 2022
+82K
Net shares
Net buyer
$99.6K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
82K acquired
Non-Derivative Transactions1
Voting Common Stock
Direct
Shares
+41K
Price / share
$2.43
Trade value
$99.63K
% of position
123.8%
9/22/2025
33.12K→74.12K
Total
Net shares
+41K
Net value
$99.63K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Voting Common Stock Direct | 9/22/2025 | P · Purchase | +41K | $2.43 | $99.63K | 123.8% | 33.12K | 74.12K |
| Total | +41K | $99.63K | ||||||
Derivative Transactions1
Common Stock Warrant (right to buy)
Direct
Converts to
Voting Common Stock
41K shares
Shares
+41K
Strike price
2.92
Held after
41K
Exercisable
—
9/22/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Common Stock Warrant (right to buy) Direct | Voting Common Stock41K shares | 9/22/2025 | P · Purchase | +41K | 2.92 | — | 41K |